Reassessment of Crohn's disease treated with at least 12 months of anti-TNF therapy: how likely is treatment withdrawal? | Frontline Gastroenterology

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

CME/CPD

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article info

Colorectal

Research

Reassessment of Crohn's disease treated with at least 12 months of anti-TNF therapy: how likely is treatment withdrawal?

Authors

R J Dart Department of Gastroenterology, Guy's and St Thomas’ IBD Centre, St Thomas’ Hospital, London, UK Diabetes and Nutritional Sciences Division, King's College London, London, UK PubMed articles Google scholar articles
N Griffin Department of Radiology, St Thomas’ Hospital, London, UK PubMed articles Google scholar articles
K Taylor Department of Gastroenterology, Guy's and St Thomas’ IBD Centre, St Thomas’ Hospital, London, UK PubMed articles Google scholar articles
J Duncan Department of Gastroenterology, Guy's and St Thomas’ IBD Centre, St Thomas’ Hospital, London, UK PubMed articles Google scholar articles
M Sastrillo Department of Gastroenterology, Guy's and St Thomas’ IBD Centre, St Thomas’ Hospital, London, UK PubMed articles Google scholar articles
J Sanderson Department of Gastroenterology, Guy's and St Thomas’ IBD Centre, St Thomas’ Hospital, London, UK Diabetes and Nutritional Sciences Division, King's College London, London, UK PubMed articles Google scholar articles
P M Irving Department of Gastroenterology, Guy's and St Thomas’ IBD Centre, St Thomas’ Hospital, London, UK Diabetes and Nutritional Sciences Division, King's College London, London, UK PubMed articles Google scholar articles

Correspondence to Dr Peter Irving, Department of Gastroenterology, St Thomas’ Hospital, Westminster Bridge Road, London SE1 7EH, UK; peter.irving{at}kcl.ac.uk

Citation

Dart RJ, Griffin N, Taylor K, et al

Reassessment of Crohn's disease treated with at least 12 months of anti-TNF therapy: how likely is treatment withdrawal?

Frontline Gastroenterology 2014;5:176-182.

Publication history

Received September 20, 2013
Revised November 24, 2013
Accepted November 26, 2013
First published December 24, 2013.

Online issue publication

April 19, 2016

Article Versions

Previous version (19 April 2016).
You are viewing the most recent version of this article.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions